Cargando…

PB2342: PROGNOSTIC SIGNIFICANCE OF PRETREATMENT NEUTROPHIL/LYMPHOCYTE RATIO, PLATELET/LYMPHOCYTE RATIO AND SYSTEMIC IMMUNE-INFLAMMATION INDEX IN PATIENTS WITH DIFFUSE LARGE B-CELL LYMPHOMA

Detalles Bibliográficos
Autores principales: Charef, Ons, Mlayah, Zaineb, Bnouni, Yasmine, Mabrouk, Nada, Boufrikha, Wiem, Nader, Slama, Boukhriss, Sarra, Laatiri, Adnene
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10429483/
http://dx.doi.org/10.1097/01.HS9.0000976088.62089.d8
_version_ 1785090725232246784
author Charef, Ons
Mlayah, Zaineb
Bnouni, Yasmine
Mabrouk, Nada
Boufrikha, Wiem
Nader, Slama
Boukhriss, Sarra
Laatiri, Adnene
author_facet Charef, Ons
Mlayah, Zaineb
Bnouni, Yasmine
Mabrouk, Nada
Boufrikha, Wiem
Nader, Slama
Boukhriss, Sarra
Laatiri, Adnene
author_sort Charef, Ons
collection PubMed
description
format Online
Article
Text
id pubmed-10429483
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Lippincott Williams & Wilkins
record_format MEDLINE/PubMed
spelling pubmed-104294832023-08-17 PB2342: PROGNOSTIC SIGNIFICANCE OF PRETREATMENT NEUTROPHIL/LYMPHOCYTE RATIO, PLATELET/LYMPHOCYTE RATIO AND SYSTEMIC IMMUNE-INFLAMMATION INDEX IN PATIENTS WITH DIFFUSE LARGE B-CELL LYMPHOMA Charef, Ons Mlayah, Zaineb Bnouni, Yasmine Mabrouk, Nada Boufrikha, Wiem Nader, Slama Boukhriss, Sarra Laatiri, Adnene Hemasphere Publication Only Lippincott Williams & Wilkins 2023-08-08 /pmc/articles/PMC10429483/ http://dx.doi.org/10.1097/01.HS9.0000976088.62089.d8 Text en Copyright © 2023 The Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access Abstract Book distributed under the Attribution-NonCommercial-NoDerivs (CC BY-NC-ND) (https://creativecommons.org/licenses/by-nc-nd/4.0/) which allows third parties to download the articles and share them with others as long as they credit the author and the Abstract Book, but they cannot change the content in any way or use them commercially.
spellingShingle Publication Only
Charef, Ons
Mlayah, Zaineb
Bnouni, Yasmine
Mabrouk, Nada
Boufrikha, Wiem
Nader, Slama
Boukhriss, Sarra
Laatiri, Adnene
PB2342: PROGNOSTIC SIGNIFICANCE OF PRETREATMENT NEUTROPHIL/LYMPHOCYTE RATIO, PLATELET/LYMPHOCYTE RATIO AND SYSTEMIC IMMUNE-INFLAMMATION INDEX IN PATIENTS WITH DIFFUSE LARGE B-CELL LYMPHOMA
title PB2342: PROGNOSTIC SIGNIFICANCE OF PRETREATMENT NEUTROPHIL/LYMPHOCYTE RATIO, PLATELET/LYMPHOCYTE RATIO AND SYSTEMIC IMMUNE-INFLAMMATION INDEX IN PATIENTS WITH DIFFUSE LARGE B-CELL LYMPHOMA
title_full PB2342: PROGNOSTIC SIGNIFICANCE OF PRETREATMENT NEUTROPHIL/LYMPHOCYTE RATIO, PLATELET/LYMPHOCYTE RATIO AND SYSTEMIC IMMUNE-INFLAMMATION INDEX IN PATIENTS WITH DIFFUSE LARGE B-CELL LYMPHOMA
title_fullStr PB2342: PROGNOSTIC SIGNIFICANCE OF PRETREATMENT NEUTROPHIL/LYMPHOCYTE RATIO, PLATELET/LYMPHOCYTE RATIO AND SYSTEMIC IMMUNE-INFLAMMATION INDEX IN PATIENTS WITH DIFFUSE LARGE B-CELL LYMPHOMA
title_full_unstemmed PB2342: PROGNOSTIC SIGNIFICANCE OF PRETREATMENT NEUTROPHIL/LYMPHOCYTE RATIO, PLATELET/LYMPHOCYTE RATIO AND SYSTEMIC IMMUNE-INFLAMMATION INDEX IN PATIENTS WITH DIFFUSE LARGE B-CELL LYMPHOMA
title_short PB2342: PROGNOSTIC SIGNIFICANCE OF PRETREATMENT NEUTROPHIL/LYMPHOCYTE RATIO, PLATELET/LYMPHOCYTE RATIO AND SYSTEMIC IMMUNE-INFLAMMATION INDEX IN PATIENTS WITH DIFFUSE LARGE B-CELL LYMPHOMA
title_sort pb2342: prognostic significance of pretreatment neutrophil/lymphocyte ratio, platelet/lymphocyte ratio and systemic immune-inflammation index in patients with diffuse large b-cell lymphoma
topic Publication Only
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10429483/
http://dx.doi.org/10.1097/01.HS9.0000976088.62089.d8
work_keys_str_mv AT charefons pb2342prognosticsignificanceofpretreatmentneutrophillymphocyteratioplateletlymphocyteratioandsystemicimmuneinflammationindexinpatientswithdiffuselargebcelllymphoma
AT mlayahzaineb pb2342prognosticsignificanceofpretreatmentneutrophillymphocyteratioplateletlymphocyteratioandsystemicimmuneinflammationindexinpatientswithdiffuselargebcelllymphoma
AT bnouniyasmine pb2342prognosticsignificanceofpretreatmentneutrophillymphocyteratioplateletlymphocyteratioandsystemicimmuneinflammationindexinpatientswithdiffuselargebcelllymphoma
AT mabrouknada pb2342prognosticsignificanceofpretreatmentneutrophillymphocyteratioplateletlymphocyteratioandsystemicimmuneinflammationindexinpatientswithdiffuselargebcelllymphoma
AT boufrikhawiem pb2342prognosticsignificanceofpretreatmentneutrophillymphocyteratioplateletlymphocyteratioandsystemicimmuneinflammationindexinpatientswithdiffuselargebcelllymphoma
AT naderslama pb2342prognosticsignificanceofpretreatmentneutrophillymphocyteratioplateletlymphocyteratioandsystemicimmuneinflammationindexinpatientswithdiffuselargebcelllymphoma
AT boukhrisssarra pb2342prognosticsignificanceofpretreatmentneutrophillymphocyteratioplateletlymphocyteratioandsystemicimmuneinflammationindexinpatientswithdiffuselargebcelllymphoma
AT laatiriadnene pb2342prognosticsignificanceofpretreatmentneutrophillymphocyteratioplateletlymphocyteratioandsystemicimmuneinflammationindexinpatientswithdiffuselargebcelllymphoma